PubRank

Masanori Sasatsu

Author PubWeight™ 34.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 2009 1.67
2 Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol 2012 1.60
3 Bactericidal activity of Ag-zeolite mediated by reactive oxygen species under aerated conditions. J Inorg Biochem 2002 1.32
4 Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999. J Med Microbiol 2005 1.18
5 Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. J Med Microbiol 2007 1.13
6 Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. Antimicrob Agents Chemother 2008 1.08
7 Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Int J Antimicrob Agents 2005 1.08
8 Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J Antimicrob Chemother 2008 1.07
9 Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus. Biol Pharm Bull 2002 1.05
10 Association of tannase-producing Staphylococcus lugdunensis with colon cancer and characterization of a novel tannase gene. J Gastroenterol 2007 1.02
11 Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J Clin Microbiol 2006 0.98
12 Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB. Helicobacter 2012 0.95
13 Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int J Antimicrob Agents 2007 0.94
14 Using the tannase gene to rapidly and simply identify Staphylococcus lugdunensis. Diagn Microbiol Infect Dis 2009 0.91
15 Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway. Biol Pharm Bull 2009 0.90
16 Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo. Int J Antimicrob Agents 2007 0.88
17 Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. J Gastroenterol Hepatol 2008 0.88
18 Anti-infectious effect of S-benzylisothiourea compound A22, which inhibits the actin-like protein, MreB, in Shigella flexneri. Biol Pharm Bull 2008 0.87
19 Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori. Microbiol Immunol 2007 0.87
20 Molecular epidemiology and antimicrobial susceptibilities of 273 exfoliative toxin-encoding-gene-positive Staphylococcus aureus isolates from patients with impetigo in Japan. J Med Microbiol 2008 0.87
21 Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces. Curr Microbiol 2005 0.87
22 Evaluation of clarithromycin resistance in Helicobacter pylori obtained from culture isolates, gastric juice, and feces. Helicobacter 2009 0.86
23 Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb Drug Resist 2004 0.85
24 Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus. Antimicrob Agents Chemother 2010 0.85
25 Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008 0.83
26 Characterization of the pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus. Plasmid 2008 0.83
27 Analysis of clarithromycin resistance and CagA status in Helicobacter pylori by use of feces from children in Thailand. J Clin Microbiol 2009 0.83
28 PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol 2013 0.83
29 Frequency and genetic characterization of multidrug-resistant mutants of Staphylococcus aureus after selection with individual antiseptics and fluoroquinolones. Biol Pharm Bull 2002 0.82
30 Transduction of the plasmid encoding antiseptic resistance gene qacB in Staphylococcus aureus. Biol Pharm Bull 2007 0.81
31 Augmentation of gene expression and production of promatrix metalloproteinase 2 by Propionibacterium acnes-derived factors in hamster sebocytes and dermal fibroblasts: a possible mechanism for acne scarring. Biol Pharm Bull 2011 0.80
32 Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes. J Dermatol 2012 0.80
33 First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris. J Dermatol 2011 0.79
34 [Antimicrobial activity and frequency of spontaneous gentamicin-resistant mutants in bacteria related skin infections]. Yakugaku Zasshi 2011 0.79
35 Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics. Clin Cosmet Investig Dermatol 2011 0.76
36 Isolation and identification of a potent antimalarial and antibacterial polyacetylene from Bidens pilosa. Planta Med 2009 0.76
37 Susceptibilities of methicillin-resistant Staphylococcus aureus isolates to seven biocides. Biol Pharm Bull 2007 0.76
38 Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan. Hepatogastroenterology 2007 0.75
39 [Survey of the attitude of master course students of clinical pharmacy toward clinical trials]. Yakugaku Zasshi 2006 0.75
40 [Subject making and evaluation method for objective structured clinical examination (OSCE) in pharmaceutical practice]. Yakugaku Zasshi 2006 0.75
41 Novel biological activity of the region (106-126) on human prion sequence. Biol Pharm Bull 2003 0.75
42 Characterization of enterococcus strains contained in probiotic products. Biol Pharm Bull 2011 0.75
43 Purification and characterization of 3,3-dihydroxyazetidine from culture medium of Bacillus mesentericus and B. subtilis. J Microbiol Methods 2002 0.75
44 A study of the relationship between Helicobacter pylori microbial susceptibility, 13C-urea breath test values. Hepatogastroenterology 2008 0.75
45 [Usefulness of small group discussion using KJ method regarding early exposure for first-year pharmaceutical science students]. Yakugaku Zasshi 2006 0.75
46 [Status and problem of first line eradication of H. pylori infection]. Nihon Rinsho 2013 0.75